Found: 5000
Select item for more details and to access through your institution.
Comparative Meta-Analysis of Triplet vs. Quadruplet Induction Regimens in Newly Diagnosed, Treatment Naïve, Multiple Myeloma.
- Published in:
- Cancers, 2024, v. 16, n. 17, p. 2938, doi. 10.3390/cancers16172938
- By:
- Publication type:
- Article
Updates on Therapeutic Strategies in the Treatment of Relapsed/Refractory Multiple Myeloma.
- Published in:
- Cancers, 2024, v. 16, n. 17, p. 2931, doi. 10.3390/cancers16172931
- By:
- Publication type:
- Article
Circulating Multiple Myeloma Cells (CMMCs) as Prognostic and Predictive Markers in Multiple Myeloma and Smouldering MM Patients.
- Published in:
- Cancers, 2024, v. 16, n. 17, p. 2929, doi. 10.3390/cancers16172929
- By:
- Publication type:
- Article
Integrating Lysosomal Genes and Immune Infiltration for Multiple Myeloma Subtyping and Prognostic Stratification.
- Published in:
- Folia Biologica (00155500), 2024, v. 70, n. 2, p. 85, doi. 10.14712/fb2024070020085
- By:
- Publication type:
- Article
Bispecific antibodies in the treatment of multiple myeloma.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01139-y
- By:
- Publication type:
- Article
Multiple myeloma survival in New South Wales, Australia, by treatment era to 2020.
- Published in:
- Cancer Biology & Medicine, 2024, v. 21, n. 8, p. 703, doi. 10.20892/j.issn.2095-3941.2024.0177
- By:
- Publication type:
- Article
Acute respiratory distress syndrome in patients with hematological malignancies: a one-year retrospective nationwide cohort study.
- Published in:
- Annals of Intensive Care, 2024, v. 14, n. 1, p. 1, doi. 10.1186/s13613-024-01373-4
- By:
- Publication type:
- Article
Relationship between reasons for intermittent missing patient-reported outcomes data and missing data mechanisms.
- Published in:
- Quality of Life Research, 2024, v. 33, n. 9, p. 2387, doi. 10.1007/s11136-024-03707-y
- By:
- Publication type:
- Article
Belantamab mafodotin, pomalidomide, and dexamethasone for triple class exposed/refractory relapsed multiple myeloma: a subgroup analysis of the ALGONQUIN trial.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01135-2
- By:
- Publication type:
- Article
Association of ADAM family members with proliferation signaling and disease progression in multiple myeloma.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01133-4
- By:
- Publication type:
- Article
Evaluation of administration-related reactions with subcutaneous daratumumab with and without premedication.
- Published in:
- Oncologist, 2024, v. 29, n. 9, p. 806, doi. 10.1093/oncolo/oyae158
- By:
- Publication type:
- Article
Construct prognostic models of multiple myeloma with pathway information incorporated.
- Published in:
- PLoS Computational Biology, 2024, v. 20, n. 9, p. 1, doi. 10.1371/journal.pcbi.1012444
- By:
- Publication type:
- Article
Navigating the clinical landscape: Update on the diagnostic and prognostic biomarkers in multiple myeloma.
- Published in:
- Molecular Biology Reports, 2024, v. 51, n. 1, p. 1, doi. 10.1007/s11033-024-09892-w
- By:
- Publication type:
- Article
Modest survival benefits of autologous stem cell transplantation in multiple myeloma with renal impairment: a critical appraisal of the pre-antibody era.
- Published in:
- Clinical & Experimental Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1007/s10238-024-01481-2
- By:
- Publication type:
- Article
Bortezomib, lenalidomide, and dexamethasone versus bortezomib, doxorubicin, and dexamethasone in newly diagnosed multiple myeloma.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12880-9
- By:
- Publication type:
- Article
Effectiveness and safety of bortezomib-dexamethasone regimen in patients with multiple myeloma: A prospective observational study.
- Published in:
- Asian Journal of Medical Sciences, 2024, v. 15, n. 8, p. 67, doi. 10.3126/ajms.v15i8.66258
- By:
- Publication type:
- Article
Calvarial multiple myeloma: Raindrop skull.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Solitary plasmacytoma of the calvarium: A successful management of a long-standing large lesion with a long-term follow-up.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Research advances in molecular biological abnormalities affecting the prognosis of multiple myeloma.
- Published in:
- Journal of Hainan Medical University, 2024, v. 30, n. 12, p. 947, doi. 10.13210/j.cnki.jhmu.20231208.001
- By:
- Publication type:
- Article
CCL17, CCL22 and their receptor CCR4 in hematologic malignancies.
- Published in:
- Discover Oncology, 2024, v. 15, n. 1, p. 1, doi. 10.1007/s12672-024-01210-x
- By:
- Publication type:
- Article
Sarcopenia Does Not Impact the Outcome of Patients with Multiple Myeloma Consolidated with Autologous Hematopoietic Stem Cell Transplantation.
- Published in:
- Chemotherapy (0009-3157), 2024, v. 69, n. 3, p. 133, doi. 10.1159/000535692
- By:
- Publication type:
- Article
Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Un myélome multiple associé à une leishmaniose viscérale : une errance diagnostique.
- Published in:
- Cahiers Santé - Médecine Thérapeutique, 2024, v. 33, n. 3, p. 169, doi. 10.1684/sanmt.2024.264
- By:
- Publication type:
- Article
Enhanced platelet function through CAR-T cell therapy in relapsed/refractory multiple myeloma.
- Published in:
- Clinical & Experimental Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1007/s10238-024-01477-y
- By:
- Publication type:
- Article
Cost-per-responder analysis of patients with lenalidomide-refractory multiple myeloma receiving ciltacabtagene autoleucel in CARTITUDE-4.
- Published in:
- Frontiers in Immunology, 2024, p. 01, doi. 10.3389/fimmu.2024.1408892
- By:
- Publication type:
- Article
A breakthrough in lymphoma therapy.
- Published in:
- Acta Haematologica Polonica, 2024, v. 55, n. 4, p. 1, doi. 10.5603/ahp.102328
- By:
- Publication type:
- Article
Therapy-related myeloid malignancies in patients with multiple myeloma.
- Published in:
- Acta Haematologica Polonica, 2024, v. 55, n. 4, p. 1, doi. 10.5603/ahp.101051
- By:
- Publication type:
- Article
The Curious Tale of a Missing Bone Segment.
- Published in:
- Turkish Journal of Hematology, 2024, v. 41, n. 3, p. 205, doi. 10.4274/tjh.galenos.2024.2024.0039
- By:
- Publication type:
- Article
Travmaya Bağlı Fraktür Gelişimi Sonucu Multipl Miyelom Tanısı Alan Hastanın Hemşirelik Bakımı: Olgu Sunumu.
- Published in:
- Journal of Ege University Nursing Faculty (JEUNF), 2024, v. 40, n. 2, p. 293, doi. 10.53490/egehemsire.1153032
- By:
- Publication type:
- Article
Exploring the promise of regulator of G Protein Signaling 20: insights into potential mechanisms and prospects across solid cancers and hematological malignancies.
- Published in:
- Cancer Cell International, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12935-024-03487-y
- By:
- Publication type:
- Article
Lenalidomide‐induced posterior reversible encephalopathy syndrome: A case report.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Expression Patterns of Eighteen Genes Involved in Crucial Cellular Processes in the TP53 Pathway in Multiple Myeloma.
- Published in:
- Gazi University Journal of Science, 2024, v. 37, n. 3, p. 1066, doi. 10.35378/gujs.1365179
- By:
- Publication type:
- Article
Impact of M‐protein detection on the response evaluations of patients undergoing treatment with the IgG‐κ monoclonal antibodies daratumumab or isatuximab, and discrepancies between immunofixation electrophoresis (IFE) systems and reagents
- Published in:
- Cancer Medicine, 2024, v. 13, n. 16, p. 1, doi. 10.1002/cam4.70128
- By:
- Publication type:
- Article
Modeling First-Line Daratumumab Use for Newly Diagnosed, Transplant-Ineligible, Multiple Myeloma: A Cost-Effectiveness and Risk Analysis for Healthcare Payers.
- Published in:
- PharmacoEconomics - Open, 2024, v. 8, n. 5, p. 651, doi. 10.1007/s41669-024-00503-9
- By:
- Publication type:
- Article
ВЪЗМОЖНОСТИ НА ОБРАЗНИЯ МЕТОД [18F]FDG-PET/CT ПРИ ПАЦИЕНТИ С МНОЖЕСТВЕН МИЕЛОМ, НАСОЧЕНИ ЗА СТАДИРАНЕ И РЕСТАДИРАНЕ ПОРАДИ СЪМНЕНИЕ ЗА ПРОГРЕСИЯ
- Published in:
- Medical Review / Meditsinski Pregled, 2024, v. 60, n. 5, p. 44
- By:
- Publication type:
- Article
Extraosseous Plasmacytomas: A Radiologist's Perspective—A Narrative Review of the Literature.
- Published in:
- Diagnostics (2075-4418), 2024, v. 14, n. 16, p. 1788, doi. 10.3390/diagnostics14161788
- By:
- Publication type:
- Article
The Role of Monoclonal Antibodies in the Treatment of Myeloma Kidney Disease.
- Published in:
- Pharmaceuticals (14248247), 2024, v. 17, n. 8, p. 1029, doi. 10.3390/ph17081029
- By:
- Publication type:
- Article
B-cell intrinsic RANK signaling cooperates with TCL1 to induce lineage-dependent B-cell transformation.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01123-6
- By:
- Publication type:
- Article
Coefficient of variation and texture analysis of 18F-FDG PET/CT images for the prediction of outcome in patients with multiple myeloma.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 9, p. 3713, doi. 10.1007/s00277-024-05905-7
- By:
- Publication type:
- Article
R2-ISS staging combined with circulating plasma cells improves risk stratification for newly diagnosed multiple myeloma: a single-center real-world study.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 9, p. 3677, doi. 10.1007/s00277-024-05806-9
- By:
- Publication type:
- Article
The role of clonal progression leading to the development of therapy-related myeloid neoplasms.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 9, p. 3507, doi. 10.1007/s00277-024-05803-y
- By:
- Publication type:
- Article
Bortezomib elevates intracellular free Fe<sup>2+</sup> by enhancing NCOA4-mediated ferritinophagy and synergizes with RSL-3 to inhibit multiple myeloma cells.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 9, p. 3627, doi. 10.1007/s00277-024-05762-4
- By:
- Publication type:
- Article
Structure-based humanization of a therapeutic antibody for multiple myeloma.
- Published in:
- Journal of Molecular Medicine, 2024, v. 102, n. 9, p. 1151, doi. 10.1007/s00109-024-02470-4
- By:
- Publication type:
- Article
Impact of Social Needs and Identity Experiences on the Burden of Illness in Patients with Multiple Myeloma: A Mixed-Methods Study.
- Published in:
- Healthcare (2227-9032), 2024, v. 12, n. 16, p. 1660, doi. 10.3390/healthcare12161660
- By:
- Publication type:
- Article
Patient Perspectives on Social and Identity Factors Affecting Multiple Myeloma Care: Barriers and Opportunities.
- Published in:
- Healthcare (2227-9032), 2024, v. 12, n. 16, p. 1587, doi. 10.3390/healthcare12161587
- By:
- Publication type:
- Article
Elevated serum levels of soluble B-cell maturation antigen as a prognostic biomarker for multiple myeloma.
- Published in:
- Clinical & Experimental Immunology, 2024, v. 217, n. 3, p. 221, doi. 10.1093/cei/uxae043
- By:
- Publication type:
- Article
A Representation of Metastatic Plasma Cell Myeloma as an Uncommonly Shaped Liver Tumor—A Case Report.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Molecular Signatures of CB-6644 Inhibition of the RUVBL1/2 Complex in Multiple Myeloma.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 16, p. 9022, doi. 10.3390/ijms25169022
- By:
- Publication type:
- Article
Prescription Drug Benefits and Survival in Myeloma Among Medicare Beneficiaries.
- Published in:
- Journal of Clinical Outcomes Management, 2018, v. 25, n. 9, p. 402
- By:
- Publication type:
- Article
SIX-MINUTE WALK TEST AS AN EXERCISE TEST FOR INPATIENTS WITH MULTIPLE MYELOMA.
- Published in:
- Cardiopulmonary Physical Therapy Journal (American Physical Therapy Association, Cardiopulmonary Section), 2006, v. 17, n. 4, p. 143, doi. 10.1097/01823246-200617040-00014
- Publication type:
- Article